Literature DB >> 28559492

Angiotensin Receptor Blockers Reduce Cardiovascular Events, Including the Risk of Myocardial Infarction.

Franz H Messerli1, Sripal Bangalore2.   

Abstract

Entities:  

Keywords:  angiotensin-converting enzyme inhibitors; hypertension; myocardial infarction

Mesh：

Substances：

Year:  2017        PMID： 28559492     DOI： 10.1161/CIRCULATIONAHA.116.025950

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  8 in total

Review 1.  The renin-angiotensin-aldosterone system: a crossroad from arterial hypertension to heart failure.

Authors:  Nicola Riccardo Pugliese; Stefano Masi; Stefano Taddei
Journal:  Heart Fail Rev       Date:  2020-01       Impact factor: 4.214

2.  Personalised Single-Pill Combination Therapy in Hypertensive Patients: An Update of a Practical Treatment Platform.

Authors:  Massimo Volpe; Giuliano Tocci; Alejandro de la Sierra; Reinhold Kreutz; Stéphane Laurent; Athanasios J Manolis; Kostantinos Tsioufis
Journal:  High Blood Press Cardiovasc Prev       Date:  2017-10-31

3.  Comparative effectiveness of ACE inhibitors and angiotensin receptor blockers in patients with prior myocardial infarction.

Authors:  Dennis Ko; Paymon Azizi; Maria Koh; Alice Chong; Peter Austin; Therese Stukel; Cynthia Jackevicius
Journal:  Open Heart       Date:  2019-05-04

4.  The impact of angiotensin-converting-enzyme inhibitors versus angiotensin receptor blockers on 3-year clinical outcomes in patients with acute myocardial infarction without hypertension.

Authors:  Ae-Young Her; Byoung Geol Choi; Seung-Woon Rha; Yong Hoon Kim; Cheol Ung Choi; Myung Ho Jeong
Journal:  PLoS One       Date:  2020-11-30       Impact factor: 3.240

5.  Elevated circulating FABP4 concentration predicts cardiovascular death in a general population: a 12-year prospective study.

Authors:  Norie Saito; Masato Furuhashi; Masayuki Koyama; Yukimura Higashiura; Hiroshi Akasaka; Marenao Tanaka; Norihito Moniwa; Hirofumi Ohnishi; Shigeyuki Saitoh; Nobuyuki Ura; Kazuaki Shimamoto; Tetsuji Miura
Journal:  Sci Rep       Date:  2021-02-17       Impact factor: 4.379

6.  Blood pressure reduction and clinical outcomes with angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers: protocol for a systematic review and meta-regression analysis.

Authors:  Jonathan A Batty; Mengyao Tang; Marlous Hall; Roberto Ferrari; Martin H Strauss; Alistair S Hall
Journal:  Syst Rev       Date:  2018-08-25

Review 7.  Angiotensin Receptor Blockers Versus Angiotensin Converting Enzyme Inhibitors for the Treatment of Arterial Hypertension and the Role of Olmesartan.

Authors:  Stefano Omboni; Massimo Volpe
Journal:  Adv Ther       Date:  2018-12-27       Impact factor: 3.845

8.  Monotherapy versus combination therapy of statin and renin-angiotensin system inhibitor in ST-segment elevation myocardial infarction.

Authors:  Yong Hoon Kim; Ae-Young Her; Myung-Ho Jeong; Byeong-Keuk Kim; Sung-Jin Hong; Seunghwan Kim; Chul-Min Ahn; Jung-Sun Kim; Young-Guk Ko; Donghoon Choi; Myeong-Ki Hong; Yangsoo Jang
Journal:  Cardiol J       Date:  2020-03-24       Impact factor: 2.737
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.